POLARx PAS: BSC Cardiac Cryoablation System Post-Approval Study |
Contract |
446,678.48 |
Clinical Trial |
Wilber Su |
COM Phx Internal Medicine |
08/2024 |
Reconfigurable MRI Technology For Safe and High-Resolution Imaging of Deep Brain Stimulation at 3T |
Grant |
69,999.00 |
Research |
Julie Pilitsis |
Neurosurgery |
08/2024 |
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) |
Contract |
167,856.00 |
Clinical Trial |
Franz Rischard |
Medicine |
08/2024 |
Recruitment of Local Health Departments for PH WINS |
Grant |
22,000.00 |
Other Sponsored Activity |
Kelly Reynolds |
Community Environment & Policy |
08/2024 |
Refining Tamoxifen Dose for Premenopausal Breast Cancer Prevention: Renaissance, a Phase II Trial |
Contract |
38,400.00 |
Clinical Trial |
Hsiao-Hui Chow |
Cancer Center Division |
08/2024 |
Sex Steroids, Kisspeptin and Regulation of GnRH |
Grant |
448,282.00 |
Research |
Sally Radovick |
Pediatrics |
08/2024 |
SOS-AMI Multi-Center, Double-Blind, Randomized , Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Self-Administered Subcutaneous Selatogrel for Prevention of All-Cause D |
Contract |
447,608.00 |
Clinical Trial |
Deepak Acharya |
Sarver Heart Center |
08/2024 |
Surveillance of Spina Bifida across the Lifespan |
Cooperative Agreement |
340,000.00 |
Other Sponsored Activity |
Jennifer Andrews |
Pediatrics |
08/2024 |
The DECIDE Registry: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management |
Contract |
119,498.00 |
Clinical Trial |
Michael Morris |
COM Phx Radiology |
08/2024 |
Therapeutics Development Center Award |
Grant |
150,472.00 |
Research |
Cori Daines |
Asthma/Airway Disease Rsch Ctr |
08/2024 |
ThinkHumanTV: Entertainment-based PsychoEducation to Enhance Emotion Skills and Reduce Psychiatric Morbidity |
Grant |
49,993.00 |
Research |
Karen Weihs |
Psychiatry |
08/2024 |
To Development a Live Attenuated Vaccine Against Coccidioidomycosis Through a Phase 1 Clinical Trial That Will Demonstrate Safety and Immunogenicity in Healthy Subjects Without Prior Exposure to the C |
Contract |
705,508.00 |
Research |
John Galgiani |
Valley Fever Ctr for Excellnc |
08/2024 |
Towards Screening With High-resolution, Low-dose, Dedicated Breast CT |
Grant |
3,258,120.00 |
Research |
Srinivasan Vedantham |
Medical Imaging |
08/2024 |
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors |
Contract |
723,979.32 |
Clinical Trial |
Jennifer Segar |
Cancer Center Division |
07/2024 |
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Tre |
Contract |
548,570.00 |
Clinical Trial |
Aaron Scott |
Cancer Center Division |
07/2024 |
A Phase 2b Multicenter, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis Eff |
Contract |
2,600.00 |
Clinical Trial |
Sasha Taleban |
Medicine |
07/2024 |
A Phase 2b, Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Treprostinil Palmitil Inhalation Powder (TPIP) |
Contract |
339,419.60 |
Clinical Trial |
Nafis Shamsid-Deen |
COM Phx Internal Medicine |
07/2024 |
A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab or TAR-200 Alone Versus In |
Contract |
12,700.00 |
Clinical Trial |
Juan Chipollini |
Cancer Center Division |
07/2024 |
A Phase Ill, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of a Single Administration Of Comp360 in Participants With Treatment- |
Contract |
994,373.92 |
Clinical Trial |
Francisco Moreno |
Senior VP Health Sciences |
07/2024 |
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke |
Contract |
422,613.00 |
Clinical Trial |
Firas Kaddouh |
Neurology |
07/2024 |